Psilocybin and LSD are on their way to legalization, but the enormous host of compounds in their phenethylamine family might not be so lucky due to a systematic problem with U.S. drug scheduling policy. This family shows enormous potential for treating some of our trickiest mental health / public health problems (addiction, depression, anxiety, OCD, and the list goes on) but the policy for newly discovered phenethylamines and tryptamines seems to be "Schedule first, worry about it later." This slows scientific research down dramatically, research that we need in order to even know in the first place whether a compound might have "high potential for abuse and no known medical potential." If there is medical potential (and in these families at least there usually is), what took days to Schedule will take millions of dollars and years or even decades to reschedule...per compound.<p>So, while I celebrate the progress being made for a couple of promising compounds with a relatively large base of recognition and support, I'm hoping that I see a more sane approach to drug policy within my lifetime (Portugal seems to be the fashionable example these days).<p>I'll also second /u/jrowley 's recommendation of Michael Pollan's recent book "How to Change Your Mind" as a good primer, and would recommend the TV show "Hamilton's Pharmacopeia" as another fascinating dive into the subject.